HER 2/neu as a theranostic marker in colorectal carcinoma and its relationship with histopathological correlates-A pilot study
Journal Title: Indian Journal of Pathology and Oncology - Year 2017, Vol 4, Issue 3
Abstract
Introduction: Colorectal carcinoma(CRC) is one among the many leading causes of cancer related mortality worldwide. The survival rate of patients with CRC is better because of advancements made in the treatment modalities, in terms of surgery and chemotherapeutic options. This study is done to know the immunoexpression of Her 2/neu in CRC and its correlation with histologic grades. Her 2/ neu is considered to be a beneficial Immunohistochemical (IHC) marker for colon cancer which can be used for predicting the prognosis and for targeted therapeutic modality. Materials and Method: The present pilot study was done to understand the expression of Her 2 /neu in histologically proven 25 cases of adenocarcinoma colon using monoclonal anti Her 2 /neu antibody (Biogenix). Positivity was recorded as per the consensus panel recommendations on Her 2/neu scoring.(1) The clinical profile of the patients were obtained from the archives in the Pathology department of our institution. Results: This study had a total of 25 hemicolectomy specimens of colorectal carcinoma. Of the total 25 cases, 14 cases (56%) were males and 11 cases (44%) were females. Forty percentage of patients were in the age group of 50-60 years. Histopathologically, most of them were adenocarcinomas. Her 2/neu expression was negative in all the 25 cases of colorectal carcinoma in our study. The control tissue was Her 2 /neu positive breast carcinoma with complete membrane staining in the tumor cells(3+). Conclusions: Her 2/neu is considered as a therapeutic modality in advanced and metastatic CRC cases. This was a pilot study and we need to perform the IHC stain on more cases to understand its expression in our population.
Authors and Affiliations
G. Priyanka, Leena Dennis Joseph, Monica Kumbhat
Invasive breast carcinoma: Correlation with the molecular subtypes and pathological response to neo-adjuvant chemotherapy
Introduction: Breast cancer is the most commonly occurring cancer in females and leading cause of cancer related deaths worldwide. The analysis of gene expression data have suggested that breast carcinoma can be divided...
Histopathological evaluation of cerebral lesions
Introduction A cerebral lesion refers to any type of abnormal tissue found in the brain particularly in the cerebral cortex The cerebrum is responsible for allowing voluntary movements within the human body Cerebral tumo...
Lymphnode cytopathology and CD4 count in HIV positive patients
Introduction CD4 is an important prognostic as well as therapeutic marker in the management of HIV and this study identifies the correlation between CD4 counts and FNAC lymphnode LN patterns in these patientsStudy Design...
Cytomorphological spectrum of pleomorphic adenoma with emphasis on differential diagnosis and diagnostic pitfalls
Introduction: Pleomorphic adenoma exhibit wide morphological spectrum varying from predominantly epithelial types to predominantly stromal types which often pose diagnostic challenge to cytopathologists. Aim: The aim of...
Cervical Cytopathology in women attending rural area at Tertiary Care Hospital
Aims and Objectives: Cervical cancer has always been a growing concern in developing countries like India. Prevent ability at pre malignant/pre invasive stages has yearned the need for studying screening methods in detai...